CTEV

Claritev Corporation
NYSEHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$384.88M
P/E Ratio
—
EPS
$-17.00
Beta
1.05
52W High
$72.67
52W Low
$11.50
50-Day MA
$27.78
200-Day MA
$25.51
Dividend Yield
—
Profit Margin
-28.50%
Forward P/E
2.76
PEG Ratio
—

About Claritev Corporation

Claritev Corporation, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company is headquartered in New York, New York.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$994.67M
Gross Profit (TTM)$725.77M
EBITDA$539.46M
Operating Margin12.80%
Return on Equity-646.00%
Return on Assets1.19%
Revenue/Share (TTM)$59.68
Book Value$-17.39
Price-to-Book43.86
Price-to-Sales (TTM)0.39
EV/Revenue5.05
EV/EBITDA10.49
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)6.60%
Shares Outstanding$16.95M
Float$6.83M
% Insiders7.33%
% Institutions83.24%

Historical Volatility

HV 10-Day
107.25%
HV 20-Day
80.72%
HV 30-Day
77.16%
HV 60-Day
77.18%
HV Rank
—

Volatility is currently expanding

Analyst Ratings

Consensus ($46.00 target)
2
Strong Buy
3
Buy
1
Hold

Latest News

Claritev Corporation Announces Participation in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

MCLEAN, Va., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and insights company, today announced that members of its management team will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Wednesday, November 11, 2026, in New York, including a presentation at 3:30 p.m. ET.

GlobeNewsWire11/5/2026Neutral
Claritev Introduces Transparency-Based Pricing, Turning Complex Public Market Data into Actionable Reimbursement Intelligence

MCLEAN, Va., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data, and insights company, today announced the launch of Transparency-Based Pricing , a new market-informed reimbursement intelligence solution designed to give payers and third-party administrators (TPAs) greater flexibility and confidence as they manage healthcare costs and reimbursement strategies.

GlobeNewsWire10/29/2026Neutral
Claritev Appoints Jennifer Main to its Board of Directors

MCLEAN, Va., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and insights company, today announced that its Board of Directors (“Board”) has appointed Jennifer (Jenni) Main as a director, effective today, filling a newly created directorship on the Board.

GlobeNewsWire10/15/2026Neutral
Claritev Corporation Announces Third Quarter 2026 Earnings Conference Call

MCLEAN, Va., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent, and fair for all, announced today that it will release its third quarter fiscal year 2026 financial results prior to market open on Monday, November 9, 2026, and hold a conference call at 8:00 am Eastern Time.

GlobeNewsWire10/14/2026Neutral
Claritev Selected by GDIT to Support CDC's World Trade Center Health Program

MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #GDIT--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center (WTC) Health Program. The WTC Health Program is a limited federal health care program established under the James Zadroga 9/11 Health and Compensation Act of 2010 (Extended in 2015). It provides nationwid.

Business Wire9/22/2026Neutral
Claritev Corporation Reports Second Quarter 2026 Results

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2026. “Claritev once again demonstrated the strength of our vision and strategy in the second quarter of 2026, delivering financial results above expectations with solid execution across the company. We are one year i.

Business Wire8/7/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CTEV and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026